Literature DB >> 8638089

B16F10 murine melanoma cells express interleukin-2 and a functional interleukin-2 receptor.

A García de Galdeano1, M D Boyano, I Smith-Zubiaga, M L Cañavate.   

Abstract

In this study, we analyzed interleukin-2 (IL-2) and IL-2 receptor (IL-2R) expression in murine B16F10 melanoma and studied the effect of recombinant IL-2 (rIL-2) on the proliferation of these cells. Flow cytometry analysis revealed the presence of the IL-2R alpha subunit in B16F10 melanoma, with a mean positivity rate of 30%. Using confocal microscopy, the expression of this chain could be visualized on the surface of B16F10 cells and in intracellular compartments when the cells were permeabilized with ethanol. In addition to the alpha subunit, the IL-2R beta subunit was also expressed in B16F10 cells as shown by reverse transcription and polymerase chain reaction analysis. The functionality of the IL-2R on B16F10 cells was shown by the fact that cell proliferation increased dose-dependently with the addition of rIL-2 to the culture medium. We also detected expression of the IL-2 gene in B16F10 cells. In Northern blot assays, a typical band of 0.9 kb corresponding to IL-2 mRNA was observed, although supernatants from B16F10 cultures had no detectable IL-2 activity. Furthermore, the addition of neutralizing antibody (anti-IL-2) to cell cultures had no effect on cell proliferation. From these results, we concluded that an IL-2 signalling system is present in murine B16F10 melanoma cells and that IL-2 favors B16F10 cell proliferation, suggesting a role for this cytokine in the tumoral activity of these cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8638089     DOI: 10.1159/000217978

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  4 in total

1.  Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.

Authors:  T Palomares; A Alonso-Varona; A Alvarez; B Castro; Y Calle; P Bilbao
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

2.  Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.

Authors:  M D Boyano; M D Garcia-Vázquez; T López-Michelena; J Gardeazabal; J Bilbao; M L Cañavate; A G Galdeano; R Izu; L Díaz-Ramón; J A Raton; J L Díaz-Pérez
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

3.  Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactions.

Authors:  Qian Wen; Wenjing Xiong; Jianchun He; Shimeng Zhang; Xialin Du; Sudong Liu; Juanjuan Wang; Mingqian Zhou; Li Ma
Journal:  J Transl Med       Date:  2016-02-05       Impact factor: 5.531

4.  Identification of a cytotoxic form of dimeric interleukin-2 in murine tissues.

Authors:  Lucile E Wrenshall; Suzanne E Clabaugh; David R Cool; Prakash Arumugam; William C Grunwald; Deandra R Smith; Gino C Liu; John D Miller
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.